The Cannabist Company Valuation Multiples

The Cannabist Company is valued at $0K as of October 2026, a 0.9x revenue multiple. In the last fiscal year, The Cannabist Company revenue was $459M and The Cannabist Company EBITDA was $25M.

The Cannabist Company Overview

About The Cannabist Company

Cannabist Company Holdings Inc through its subsidiaries, operates as a cultivator, manufacturer, and provider of medical and adult-use cannabis products. Some of its products are vaporization oil, sublingual tinctures, lotions, hard-pressed tablets, and suppositories, among others which are marketed through brands like Classix, dreamt, Triple Seven, Amber, Press, Heady, and Seed and Strain. The company operates its businesses in California, Colorado, Delaware, Illinois, Maryland, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, Virginia, and West Virginia.


Founded

2018

HQ

United States

Employees

1.6K

Financials (Last FY)

Revenue: $459M
EBITDA: $25M

EV

$424M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

The Cannabist Company Financials

The Cannabist Company reported last fiscal year revenue of $459M and EBITDA of $25M.

In the same fiscal year, The Cannabist Company generated $168M in gross profit, $25M in EBITDA, and had net loss of ($106M).

Revenue (LTM)


The Cannabist Company P&L

In the most recent fiscal year, The Cannabist Company reported revenue of $459M and EBITDA of $25M.

The Cannabist Company is unprofitable as of last fiscal year, with gross margin of 37%, EBITDA margin of 5%, and net margin of (23%).

See analyst estimates for The Cannabist Company
Last FY20232024202620272028
Revenue$459M$511M$459M
Gross Profit$168M$180M$168M
Gross Margin37%35%37%
EBITDA$25M($55M)$25M
EBITDA Margin5%(11%)5%
EBIT Margin(4%)(4%)(4%)
Net Profit($106M)($176M)($106M)
Net Margin(23%)(34%)(23%)
Net Debt$281M--

Financial data powered by Morningstar, Inc.

The Cannabist Company Stock Performance

The Cannabist Company has current market cap of $0K, and enterprise value of $424M.

Market Cap Evolution


The Cannabist Company's stock price is $0.00.

The Cannabist Company share price decreased by 99.0% in the last 30 days, and by 100.0% in the last year.

The Cannabist Company has an EPS (earnings per share) of $-0.21.

See more trading valuation data for The Cannabist Company
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$424M$0K0.0%-99.0%-99.7%-100.0%$-0.21

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

The Cannabist Company Valuation Multiples

The Cannabist Company trades at 0.9x EV/Revenue multiple, and 16.9x EV/EBITDA.

See NTM and 2027E valuation multiples for The Cannabist Company

EV / Revenue (LTM)


The Cannabist Company Financial Valuation Multiples

As of October 28, 2026, The Cannabist Company has market cap of $0K and EV of $424M.

The Cannabist Company has a P/E ratio of 0.0x.

Last FY20232024202620272028
EV/Revenue0.9x0.8x0.9x
EV/EBITDA16.9x(7.6x)16.9x
EV/EBIT(21.1x)(21.6x)(21.1x)
EV/Gross Profit2.5x2.4x2.5x
P/E0.0x0.0x0.0x
EV/FCF(14.5x)(169.9x)(14.5x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified The Cannabist Company Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

The Cannabist Company Margins & Growth Rates

In the most recent fiscal year, The Cannabist Company reported gross margin of 37%, EBITDA margin of 5%, and net margin of (23%).

See estimated margins and future growth rates for The Cannabist Company

The Cannabist Company Margins

Last FY20242026202720282029
Gross Margin37%37%-
EBITDA Margin5%5%6%
EBIT Margin(4%)(4%)-
Net Margin(23%)(23%)-
FCF Margin(6%)(6%)-

The Cannabist Company Growth Rates

23/2426/2727/2828/29
Revenue Growth(10%)
Gross Profit Growth(6%)
EBITDA Growth(145%)
EBIT Growth2%
Net Profit Growth(40%)
FCF Growth1071%

Data powered by FactSet, Inc. and Morningstar, Inc.

The Cannabist Company Operational KPIs

The Cannabist Company's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for The Cannabist Company
Last FY20232024202620272028
Revenue per Employee$0.3M--
Opex per Employee$0.1M--
S&M Expenses to Revenue1%1%1%
G&A Expenses to Revenue15%11%15%
Opex to Revenue42%56%42%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

The Cannabist Company Competitors

The Cannabist Company competitors include Sonder Holdings, Indoor Harvest, Ubiquitech Software, Pineapple, Green Leaf Innovations, Resonate Blends, 1606, RAMM Pharma and Digicann Ventures.

Most The Cannabist Company public comparables operate across Cannabis, Specialty Stores, CannaTech and ViceTech.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Sonder Holdings$621M($4M)2.3x-(380.8x)-
Indoor Harvest-($2M)--(0.0x)-
Ubiquitech Software------
Pineapple-($8M)--(0.0x)-
Green Leaf Innovations------
Resonate Blends$2M($981K)3.4x-(5.9x)-
1606-($341K)--(7.2x)-

This data is available for Pro users. Sign up to see all The Cannabist Company competitors and their valuation data.

Start Free Trial

The Cannabist Company VC Funding History

Before going public, The Cannabist Company raised $50M in total equity funding, across 2 rounds.


The Cannabist Company Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Nov-18Undisclosed stageLVL1 Group$46M--
May-14Seed-$4M--

Acquisitions by The Cannabist Company

The Cannabist Company has acquired 9 companies to date.

Last acquisition by The Cannabist Company was on August 12th 2022. The Cannabist Company acquired Medicine Man Longmont for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by The Cannabist Company

Medicine Man Longmont
Medicine Man Denver
Green Leaf Medical of Ohio II
CannAscend Ohio dispensary business
Description
Medicine Man Longmont, LLC is the cannabis dispensary company covered by a separate purchase option granted to Columbia Care alongside its acquisition of the wider Medicine Man business in 2021. The option was exercised in August 2022 after the buyer disposed of its existing Green Solution dispensary in Longmont, as required under the transaction agreement. The business operates within Colorado’s regulated cannabis retail market and is distinct from Futurevision Holdings and Futurevision 2020, the two entities transferred in the earlier acquisition. Its subsequent acquisition expanded the buyer’s Medicine Man retail operations while addressing the conditions attached to local ownership approvals. It is also separate from Medicine Man Technologies, the listed cannabis company associated with the Schwazze brand. The legal entity was identified by name in Columbia Care’s acquisition disclosures.
Medicine Man Denver is a medical cannabis dispensary in Colorado offering organic, locally cultivated strains. It provides flower, edibles, and concentrates compliant with state regulations. Denver-based since 2010, the operation emphasizes patient education and quality control in its cultivation facility.
Green Leaf Medical of Ohio II, LLC was an Ohio cannabis dispensary company within the Green Leaf Medical group. The business operated a retail dispensary in Warren and formed part of the medical cannabis network acquired by Columbia Care in 2021. Following the acquisition of its parent group in June, Columbia Care purchased the remaining 49 percent ownership interest in this specific subsidiary in July. That purchase completed ownership of the company and was accounted for separately from the initial group acquisition. The company’s operating role was the retail sale of cannabis products to eligible patients under Ohio’s regulated medical cannabis programme. It was distinct from Greenleaf Apothecaries, Greenleaf Gardens and Greenleaf Therapeutics, the Ohio businesses acquired by Acreage Holdings later in 2021.
CannAscend was an Ohio medical cannabis retail business comprising CannAscend Alternative, LLC and CannAscend Alternative Logan, LLC. The two companies operated four dispensaries located in Dayton, Logan, Marietta and Monroe. Columbia Care acquired their outstanding membership interests in July 2021 after previously purchasing an option over the businesses in 2018. All four dispensaries had received certificates of operation under Ohio’s medical marijuana programme by the fourth quarter of 2019. Their addition expanded Columbia Care’s retail network alongside cultivation and manufacturing operations elsewhere in the state. The acquired perimeter comprised the four operating dispensaries held through the two named companies, which were consolidated together following completion. It did not comprise Columbia Care’s separately acquired Green Leaf dispensary in Warren or its other Ohio production facilities.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
Longmont
Denver, CO
Warren
-
Deal Date12 Aug 20221 Nov 20217 Jul 20211 Jul 2021
Valuationundisclosed$42Mundisclosed$14M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all The Cannabist Company acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by The Cannabist Company

The Cannabist Company has invested in 1 company to date.

Latest investment by The Cannabist Company was on June 25th 2019. The Cannabist Company invested in The Nue Co. in their $9M Series A round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by The Cannabist Company

The Nue Co.
Description
The Nue Co. is a supplement brand that formulates products from organic foods rich in vitamins and minerals, avoiding isolated synthetics and fillers. Based in Cambridge, England, the lab draws on over 20 years of expertise to create traceable blends like magnesium from sea water and vitamin D from lichen. Founded after a 2016 trip to Copenhagen, the company emphasizes simplicity and purity in items such as stress-relief supplements and prebiotics. The Nue Co. minimizes plastic use with recyclable glass jars and ships worldwide from its UK facility.
HQ CountryUnited States
HQ City
New York City, NY
Deal Date25 Jun 2019
RoundSeries A
Raised$9M
InvestorsUnilever Ventures; AF Ventures; REDO Ventures; Waldencast; The Cannabist Company
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all The Cannabist Company investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About The Cannabist Company

When was The Cannabist Company founded?The Cannabist Company was founded in 2018.
Where is The Cannabist Company headquartered?The Cannabist Company is headquartered in United States.
How many employees does The Cannabist Company have?As of today, The Cannabist Company has over 1K employees.
Is The Cannabist Company publicly listed?Yes, The Cannabist Company is a public company listed on OTCM.
What is the stock symbol of The Cannabist Company?The Cannabist Company trades under CBSTQ ticker.
When did The Cannabist Company go public?The Cannabist Company went public in 2019.
Who are competitors of The Cannabist Company?The Cannabist Company main competitors include Sonder Holdings, Indoor Harvest, Ubiquitech Software, Pineapple, Green Leaf Innovations, Resonate Blends, 1606, RAMM Pharma, Digicann Ventures.
What is the current market cap of The Cannabist Company?The Cannabist Company's current market cap is $0K.
What is the current revenue of The Cannabist Company?The Cannabist Company's last fiscal year revenue is $459M.
What is the current EV/Revenue multiple of The Cannabist Company?Current revenue multiple of The Cannabist Company is 0.9x.
Is The Cannabist Company profitable?No, The Cannabist Company is not profitable.
How many companies The Cannabist Company has acquired to date?As of October 2026, The Cannabist Company has acquired 9 companies.
What was the largest acquisition by The Cannabist Company?$240M acquisition of Green Leaf Medical on 11th June 2021 was the largest M&A The Cannabist Company has done to date.
What companies The Cannabist Company acquired?The Cannabist Company acquired Green Leaf Medical, The Green Solution, Project Cannabis, Medicine Man Denver, The Healing Center San Diego, CannAscend Ohio dispensary business, Corsa Verde, Medicine Man Longmont, and Green Leaf Medical of Ohio II.
In how many companies The Cannabist Company has invested to date?As of October 2026, The Cannabist Company has invested in 1 company.
What was the last The Cannabist Company investment?On 25th June 2019 The Cannabist Company invested in The Nue Co., participating in a $9M Series A round, alongside Unilever Ventures, AF Ventures, REDO Ventures, and Waldencast.
In what companies The Cannabist Company invested in?The Cannabist Company invested in The Nue Co..

See public comps similar to The Cannabist Company

Lists including The Cannabist Company

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial